These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25798370)

  • 1. Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
    Pfaar O; Gerth van Wijk R
    Curr Treat Options Allergy; 2015; 2(1):1-9. PubMed ID: 25798370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ
    Vitiello G; Maltagliati L; Rossi O
    Clin Mol Allergy; 2020; 18():10. PubMed ID: 32536827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
    Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
    Front Immunol; 2021; 12():786738. PubMed ID: 35197963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis.
    Feng M; Zeng X; Li J
    J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
    Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
    Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
    J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis.
    Mösges R; Valero Santiago A; Allekotte S; Jahed N; Astvatsatourov A; Sager A; Sánchez-López J
    Clin Transl Allergy; 2019; 9():29. PubMed ID: 31171962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory allergy caused by house dust mites: What do we really know?
    Calderón MA; Linneberg A; Kleine-Tebbe J; De Blay F; Hernandez Fernandez de Rojas D; Virchow JC; Demoly P
    J Allergy Clin Immunol; 2015 Jul; 136(1):38-48. PubMed ID: 25457152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis.
    Meteran H; Backer V
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1127-1133. PubMed ID: 31584839
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial.
    Bożek A; Kołodziejczyk K; Kozłowska R; Canonica GW
    Clin Transl Allergy; 2017; 7():43. PubMed ID: 29214012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. House dust mite allergy: Its innate immune response and immunotherapy.
    Huang FL; Liao EC; Yu SJ
    Immunobiology; 2018 Mar; 223(3):300-302. PubMed ID: 29079219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen Immunotherapy in Asthma.
    Nakagome K; Nagata M
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: Time for a change?
    Calderón MA; Bousquet J; Canonica GW; Cardell LO; Fernandez de Rojas DH; Kleine-Tebbe J; Demoly P
    J Allergy Clin Immunol; 2017 Jul; 140(1):41-52. PubMed ID: 28526624
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.